查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587340

伴同性動物疫苗市場：依產品類型、動物類型、通路分類 - 全球預測 2025-2030 年

Companion Animal Vaccine Market by Product Type (Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine), Animal Type (Canine, Equine, Feline), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年伴同性動物疫苗市值為46.1億美元，預計2024年將達到49.7億美元，複合年成長率為8.18%，預計到2030年將達到80.1億美元。

伴同性動物疫苗市場是獸醫醫學領域中一個充滿活力的領域，專注於疫苗接種解決方案，以保護狗、貓、鳥和兔子等寵物免受感染疾病的侵害。疫苗對於預防傳染病的爆發和確保動物的福祉極為重要，最終改善動物和與之互動的人類的生活品質。市場應用範圍從單一疫苗到為獸醫診所、醫院和寵物飼主設計的多效價解決方案。寵物擁有量的增加以及人們對寵物健康意識的提高正在推動市場的成長。此外，DNA疫苗和重組載體疫苗等疫苗開發技術的進步為創新提供了有利的機會。影響成長的關鍵因素是監管機構強制實施某些疫苗接種，凸顯了對這些產品的需求。然而，挑戰包括高昂的研發成本和嚴格的監管核准，可能會阻止新參與企業快速進入市場。此外，寵物尋求整體護理和替代醫學的趨勢可能與廣泛接種疫苗相矛盾。從地區來看，由於可支配收入的增加和寵物護理標準的變化，新興市場存在潛在的成長機會。公司可以透過投資在地化研究和製定在地化策略來利用這些機會。導致業務成長的創新領域包括研究口服疫苗等新的給藥系統以及延長現有疫苗的保存期限。基於動物基因譜分析客製化疫苗解決方案也很重要。儘管面臨挑戰，市場對寵物健康的積極態度繼續為成長提供重要途徑，其中研發發揮關鍵作用。相關人員必須了解監管環境並投資於教育和宣導活動，以最大限度地提高潛在的市場滲透率和永續性。

主要市場統計
基準年[2023] 46.1億美元
預測年份 [2024] 49.7億美元
預測年份 [2030] 80.1億美元
複合年成長率（%） 8.18%

市場動態：揭示快速發展的伴同性動物疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變伴同性動物疫苗市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 伴同性動物世界的普及
    • 伴同性動物疾病盛行率增加
    • 增加消費者在動物健康和福利方面的支出
  • 市場限制因素
    • 疫苗高成本，政府框架不利
  • 市場機會
    • 持續推進疫苗接種，組織動物福利工作
    • 寵物保險的可用性和寵物保險服務供應商的普及率
  • 市場挑戰
    • 動物疫苗接種的不良反應

波特的五力：駕馭伴同性動物疫苗市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解伴同性動物疫苗市場的外部影響

外部宏觀環境因素在塑造伴同性動物疫苗市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解伴同性動物疫苗市場的競爭狀況

伴同性動物疫苗市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣伴同性動物疫苗市場供應商的績效評估

FPNV定位矩陣是評估伴同性動物疫苗市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了伴同性動物疫苗市場的成功之路

對於希望加強在全球市場的影響力的公司來說，伴同性動物疫苗市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地寵物擁有量呈上升趨勢
      • 寵物疾病增加
      • 增加消費者在動物健康和福利方面的支出
    • 抑制因素
      • 疫苗高成本，政府框架不利
    • 機會
      • 持續的疫苗接種工作和動物福利組織工作
      • 寵物保險的可用性和寵物保險服務提供者的滲透率
    • 任務
      • 動物疫苗接種的負面影響
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章伴同性動物疫苗市場：依產品類型

  • 減毒活病毒疫苗
  • 結合疫苗
  • DNA疫苗
  • 去活化疫苗
  • 重組疫苗
  • 次單位疫苗
  • 類毒素疫苗

第7章依動物類型分類的伴同性動物疫苗市場

  • 狗
  • 馬
  • 貓科動物

第8章伴同性動物疫苗市場：依通路分類

  • 獸醫診所
  • 動物醫院
  • 獸醫研究組織

第9章美洲伴同性動物疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區伴同性動物疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲伴同性動物疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Biogenesis Bago
  • Biovet Private Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health
  • Hester Biosciences Limited
  • Hipra Laboratories, SA
  • ImmuCell Corporation
  • Merck & Co.
  • Neogen Corporation
  • Novartis AG
  • Ourofino Animal Health
  • Phibro Animal Health Corporation
  • Sanofi SA
  • Virbac Group
Product Code: MRR-957C47F94D1F

The Companion Animal Vaccine Market was valued at USD 4.61 billion in 2023, expected to reach USD 4.97 billion in 2024, and is projected to grow at a CAGR of 8.18%, to USD 8.01 billion by 2030.

The companion animal vaccine market is a dynamic segment within the larger veterinary medicine field, focusing on immunization solutions to safeguard pets like dogs, cats, birds, and rabbits from infectious diseases. Vaccines are crucial in preventing outbreaks and ensuring animal welfare, ultimately enhancing the quality of life for both animals and humans who interact with them. The market applications range from single vaccines to multivalent solutions, designed for veterinary clinics, hospitals, and pet owners. Increasing pet ownership, coupled with rising awareness about pet health, is driving market growth. Additionally, technological advancements in vaccine development such as DNA vaccines and recombinant vector vaccines offer lucrative opportunities for innovation. A significant factor influencing growth is the compulsion for certain vaccinations by regulatory authorities, which underscores the necessity of these products. However, the market faces challenges, including high costs of R&D and stringent regulatory approvals which could inhibit rapid market entry for new players. Furthermore, a growing trend toward holistic and alternative pet health care can sometimes conflict with vaccination uptake. Geographically, emerging markets present potential growth opportunities due to increasing disposable incomes and changing pet care standards. Companies can capitalize on these opportunities by investing in localized research and developing region-specific strategies. Areas of innovation conducive to business growth include exploring novel delivery systems such as oral vaccines and extending the efficacy duration of existing vaccines. It's also valuable to delve into customized vaccine solutions based on the genetic profiling of animals. Despite its challenges, the market's proactive stance on pet health continues to offer significant growth avenues, with research and development playing a crucial role. Stakeholders must navigate regulatory landscapes and invest in education and awareness initiatives to maximize potential market penetration and sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 4.61 billion
Estimated Year [2024] USD 4.97 billion
Forecast Year [2030] USD 8.01 billion
CAGR (%) 8.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Vaccine Market

The Companion Animal Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of companion animals worldwide
    • Growing prevalence of companion animal disorders
    • Rising consumer expenditure for animal health and welfare
  • Market Restraints
    • High costs of vaccines and unfavorable governmental frameworks
  • Market Opportunities
    • Ongoing vaccination drives and organizational efforts for animal welfare
    • Availability of pet insurance and penetration of pet insurance service providers
  • Market Challenges
    • Adverse impacts of animal vaccination

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Vaccine Market

A detailed market share analysis in the Companion Animal Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Companion Animal Vaccine Market

A strategic analysis of the Companion Animal Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Vaccine Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago, Biovet Private Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health, Hester Biosciences Limited, Hipra Laboratories, S.A., ImmuCell Corporation, Merck & Co., Neogen Corporation, Novartis AG, Ourofino Animal Health, Phibro Animal Health Corporation, Sanofi S.A., and Virbac Group.

Market Segmentation & Coverage

This research report categorizes the Companion Animal Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Attenuated Live Vaccine, Conjugate Vaccine, DNA Vaccine, Inactivated Vaccine, Recombinant Vaccine, Subunit Vaccine, and Toxoid Vaccine.
  • Based on Animal Type, market is studied across Canine, Equine, and Feline.
  • Based on Distribution Channel, market is studied across Veterinary Clinics, Veterinary Hospitals, and Veterinary Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of companion animals worldwide
      • 5.1.1.2. Growing prevalence of companion animal disorders
      • 5.1.1.3. Rising consumer expenditure for animal health and welfare
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of vaccines and unfavorable governmental frameworks
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing vaccination drives and organizational efforts for animal welfare
      • 5.1.3.2. Availability of pet insurance and penetration of pet insurance service providers
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse impacts of animal vaccination
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Companion Animal Vaccine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Attenuated Live Vaccine
  • 6.3. Conjugate Vaccine
  • 6.4. DNA Vaccine
  • 6.5. Inactivated Vaccine
  • 6.6. Recombinant Vaccine
  • 6.7. Subunit Vaccine
  • 6.8. Toxoid Vaccine

7. Companion Animal Vaccine Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Canine
  • 7.3. Equine
  • 7.4. Feline

8. Companion Animal Vaccine Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Veterinary Clinics
  • 8.3. Veterinary Hospitals
  • 8.4. Veterinary Research Institutes

9. Americas Companion Animal Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Companion Animal Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Companion Animal Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biogenesis Bago
  • 2. Biovet Private Ltd.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Ceva Sante Animale
  • 5. Elanco Animal Health
  • 6. Hester Biosciences Limited
  • 7. Hipra Laboratories, S.A.
  • 8. ImmuCell Corporation
  • 9. Merck & Co.
  • 10. Neogen Corporation
  • 11. Novartis AG
  • 12. Ourofino Animal Health
  • 13. Phibro Animal Health Corporation
  • 14. Sanofi S.A.
  • 15. Virbac Group

LIST OF FIGURES

  • FIGURE 1. COMPANION ANIMAL VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. COMPANION ANIMAL VACCINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPANION ANIMAL VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPANION ANIMAL VACCINE MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ATTENUATED LIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2023